<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230409057861N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-08</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of rosa and peppermint scents on postoperative pain and anxiety in  children with abdominal surgery</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of rosa and peppermint scents on postoperative pain and anxiety in 6-12 years children with abdominal surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-03-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>36</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69487</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Other, Purpose: Education/Guidance, Randomization description: Allocation of samples in groups is done using random block method.  In order to equalize the distribution of gender confounding variables and the level of anxiety before the intervention, first classes based on these variables as described by girl/boy and mild (≥17)/moderate (18-24)/severe (25-30)/very severe anxiety  (&lt;30) are created and then they are balanced in the studied groups by random block method, Blinding description: This study is one-sided blind and the statistical consultant is blind.  After collecting the data without identifying the intervention and control groups, descriptive statistics are used to describe the data, calculating central and dispersion indices for quantitative variables and frequency and percentage for qualitative variables.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Abdominal surgery.</hc_freetext>
      <i_freetext>Intervention group: In the intervention groups, 2 drops of rose essential oil or peppermint will be poured on a pad soaked in normal saline and will be attached to the collar of the child's clothes for half an hour. Immediately after removing the pad, the child's pain and anxiety will be measured. In the control group,  A pad soaked in unscented normal saline will be used.  The anxiety of the units studied by the researcher and assistant researchers one hour after the child's hospitalization before receiving the scent and 8 hours after hospitalization, 9, 12 and 16 hours after the operation and receiving the scent half an hour before the above hours with the Hamilton tool through an interview with the mother by the researchers  will be measured. Also, children's pain will be measured using Flak tool upon entering from the operating room to the ward before giving the aroma at half, three, six, nine, twelve and sixteen hours after the operation and receiving the aroma for half an hour by the researcher and assistant researchers..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is The result was unclear due to the reason</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra nadri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam khomeyni</address>
        <city>Aleshtar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6895113435</zip>
        <telephone>0098 58282618</telephone>
        <email>Z.nadri77@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Nadri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golshan Alley 7,  Yadgar Imam Square, Imam Khomeini Ave</address>
        <city>Aleshtar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6895113435</zip>
        <telephone>0098 58282618</telephone>
        <email>Z.nadri7@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having both parents
Children should be 6 to 12 years old
The child should be awake before the surgery
Always accompany the child and only the mother
Verbal consent of the child to participate in the stud
Ability of child and mother to communicate verbally
Performing elective abdominal surgery in children
Presence of the child and mother at least 12 hours before and 18 hours after the operation in the ward</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Prolonging surgery in the operating room
Having complications during surgery and complications of anesthesia (severe hypothermia)
The occurrence of unwanted complications after surgery such as bleeding, opening of the surgical site, etc.
Need for ICU after surgery
Child's and mother's unwillingness to continue the research
Moving the child to another department/hospital Discharge of children from the hospital with personal consent
the impossibility of the parent being with the child during the entire period of hospitalization for any reason (illness, personal problems, etc
Disruption in completing the anxiety questionnaire by the mother
Occurrence of symptoms of allergy to scents in the child or mother during the study
Patients with acute problems and undergoing emergency surgeries
The child has multiple surgical incisions
Performing major abdominal surgeries (volvulus, laparotomy obstruction) and multiple incisions
History of surgery or hospitalization in the child
Physical and metabolic diseases such as diabetes and phenylketonuria in children
History of allergic rhinitis in child and mother
History of respiratory, skin and dermatitis sensitivity in child and mother
The presence of chronic pain in children
Taking painkillers or sedatives during 24 hours before abdominal surgery by the child
Taking nerve medication or suffering from nerve diseases such as anxiety and depression, hyperactivity and autism
Use of hypnotics, sedatives or benzodiazepines by the child within a week before the start of the intervention.
Use of systemic painkillers such as ibuprofen and acetaminophen before surgery in children
Use of complementary medicine methods (aromatherapy, etc.) for the child and parents for a week before the intervention.
A child suffering from mental retardation
Obvious cognitive, psychological or physical problems in parents and children</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z40.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Encounter for other prophylactic surgery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention groups, 2 drops of rose essential oil or peppermint will be poured on a pad soaked in normal saline and will be attached to the collar of the child's clothes for half an hour. Immediately after removing the pad, the child's pain and anxiety will be measured. In the control group,  A pad soaked in unscented normal saline will be used.  The anxiety of the units studied by the researcher and assistant researchers one hour after the child's hospitalization before receiving the scent and 8 hours after hospitalization, 9, 12 and 16 hours after the operation and receiving the scent half an hour before the above hours with the Hamilton tool through an interview with the mother by the researchers  will be measured. Also, children's pain will be measured using Flak tool upon entering from the operating room to the ward before giving the aroma at half, three, six, nine, twelve and sixteen hours after the operation and receiving the aroma for half an hour by the researcher and assistant researchers.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Percentage of children candidates for abdominal surgery. Timepoint: Hospitalization time in the ward and before aromatherapy, immediately after the operation and at half an hour, 3, 6, 9, 12 and 16 hours after the operation. Method of measurement: Data collection tools in this research include the demographic information collection form, FLACC pain behavioral reaction checklist, and Hamilton's anxiety questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Blood oxygen saturation percentage. Timepoint: at the time of entering the ward and before aromatherapy, and at half, 3, 6, 9, 12 and 16 hours after the operation. Method of measurement: Pulse oximetry device.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khoram-Abad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-04</approval_date>
        <contact_name>Ethics Committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>Moalem ave Khoram Abad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
